is a classic case of an oversold value stock right now but smart investors can spot that. I see the bid support is starting to rise today. Makes sense with the company's Q3 report coming up that we have already been told by management will reflect a continuing positive sales growth trend for the increasingly popular Seratopical Revolution skin care line.
"...we are encouraged by the early results and accelerating sales heading into the third quarter, which reaffirms the improving overall trajectory of the business. As mentioned in our first quarter earnings announcement, the proceeds from the July 2022 asset sale allowed us to invest in the future of the Company, but the delay in receiving the balance of the proceeds versus our expectations had a negative impact on our second quarter performance. Our margin expansion initiatives continue to deliver results, and we are moving forward with our efforts to further reduce SG&A expenses and to maximize operating leverage.
We are also very excited by the continued success of the advertising and marketing campaigns for our Seratopical Revolution product line. theSkimm continues to deliver as we execute on our strategy to build our brands," said Nancy Duitch, Avenir CEO.